Recruiting NA INTERVENTIONAL 1-arm NCT06689176

Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion

Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion After Chlorhexidine Irrigation in Patients Undergoing Radical Cystectomy

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions Bladder Cancer Urinary Tract Infection

Interventions Irrisept® Antimicrobial Wound Lavage

Updated 2 times since 2024 Last updated: Dec 8, 2025 Started: Aug 1, 2024 Primary completion: Jul 1, 2026 Completion: Jul 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Bladder Cancer and Urinary Tract Infection, this trial is actively recruiting participants. The trial is conducted by Icahn School of Medicine at Mount Sinai and has accumulated 2 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

2 versions recorded

Jan 2026 — Present [monthly]

Recruiting NA
Dec 2024 — Jan 2026 [monthly]

Recruiting NA

First recorded

Aug 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Icahn School of Medicine at Mount Sinai
Irrimax Corporation

Data source: Icahn School of Medicine at Mount Sinai

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States